Our results reveal the association between ferroptosis and tumour‐infiltrating immune cells with dysregulated MGST1, which has the potential to be designed for ferroptosis inducer, and provide promising combinational therapy strategies in the future. The gene discussed is MGST1; the disease is neoplasm.